Phase I/Ib study of the PARP inhibitor olaparib (O) with carboplatin (C) in BRCA1/2 mutation carriers with breast or ovarian cancer (Br/OvCa) (NCT00647062).
Jung-min Lee
No relevant relationships to disclose
Christina M. Annunziata
No relevant relationships to disclose
John L. Hays
No relevant relationships to disclose
Anne M. Noonan
No relevant relationships to disclose
Lori M. Minasian
No relevant relationships to disclose
JoAnne Zujewski
No relevant relationships to disclose
Minshu Yu
No relevant relationships to disclose
Jiuping Jay Ji
No relevant relationships to disclose
Tristan Sissung
No relevant relationships to disclose
Nicole D. Houston
No relevant relationships to disclose
Elise C. Kohn
No relevant relationships to disclose